Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.32 USD | -0.61% | -0.47% | -28.86% |
Financials (USD)
Sales 2024 * | 26.32M | Sales 2025 * | 163M | Capitalization | 1.94B |
---|---|---|---|---|---|
Net income 2024 * | -260M | Net income 2025 * | -219M | EV / Sales 2024 * | 66.2 x |
Net cash position 2024 * | 193M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 11.2 x |
P/E ratio 2024 * |
-7.87
x | P/E ratio 2025 * |
-10.1
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | -0.61% | ||
1 week | -0.47% | ||
1 month | -0.93% | ||
3 months | -27.24% | ||
6 months | -8.62% | ||
Current year | -28.86% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 46 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 21.32 | -0.61% | 554,881 |
24-05-30 | 21.45 | +3.82% | 683,734 |
24-05-29 | 20.66 | -1.34% | 908,061 |
24-05-28 | 20.94 | -2.24% | 1,081,531 |
24-05-24 | 21.42 | -1.38% | 584,227 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.86% | 1.94B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RCKT Stock